Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Nevedomskaya, Ekaterina, Reichert, Kristin, Steuber, Holger, Lejeune, Pascale, Mumberg, Dominik, Haendler, Bernard
Published in International journal of cancer (01.09.2019)
Published in International journal of cancer (01.09.2019)
Get full text
Journal Article
Abstract A028: In vitro and in vivo efficacy of the androgen receptor antagonist darolutamide in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Reichert, Kristin, Lejeune, Pascale, Haendler, Bernard
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Get full text
Journal Article